| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/25/1995 | CA1335354C Anti-pci monoclonal antibody |
| 04/20/1995 | WO1995010777A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | WO1995010776A1 Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010606A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | WO1995010540A1 Fas antagonists and uses thereof |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010536A1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 04/20/1995 | WO1995010512A1 An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 04/20/1995 | WO1995010300A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains and methods of making same |
| 04/20/1995 | CA2178341A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2174132A1 Fas antagonists and uses thereof |
| 04/20/1995 | CA2173606A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof |
| 04/20/1995 | CA2172271A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/19/1995 | EP0648842A2 Truncated human cholesterol 7alpha-hydroxylase, method of production and use thereof |
| 04/19/1995 | EP0648840A2 Cholesterol 7alpha-hydroxylase gene regulatory elements and transcription factors |
| 04/19/1995 | EP0648783A1 TNF inhibitors |
| 04/19/1995 | EP0648501A1 Compositions comprising G-CSF for treating or preventing infections in canine and feline animals |
| 04/19/1995 | EP0648276A1 Monoclonal antibodies to glycoprotein p |
| 04/19/1995 | EP0648275A1 Method for the epigenetic regulation of protein biosynthesis by scale resonance |
| 04/19/1995 | EP0648271A1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/19/1995 | EP0648270A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 04/19/1995 | EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 04/19/1995 | EP0648266A1 Elicitor of the hypersensitive response in plants |
| 04/19/1995 | EP0648261A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 04/19/1995 | EP0648260A1 Fusobacterium necrophorum leukotoxoid vaccine |
| 04/19/1995 | EP0648228A1 Bnp antibody and immunoassay using it |
| 04/19/1995 | EP0648227A1 Improvements in or relating to neuroregeneration |
| 04/19/1995 | EP0436016B1 Chimeric anti-cea antibody |
| 04/19/1995 | EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 04/19/1995 | EP0388466B1 NUCLEIC ACID CODING FOR THE HUMAN ANGIOTENSINE CONVERSION ENZYME (ACE), AND ITS APPLICATIONS PARTICULARLY FOR THE $i(IN VITRO) DIAGNOSIS OF HIGH BLOOD PRESSURE |
| 04/19/1995 | CN1028206C Purification of pertussis antigens |
| 04/18/1995 | US5408041 Multiple elutions with Sepharose, Sephacryl, HPLC; for bone disorders, osteoporosis, Paget*s disease |
| 04/18/1995 | US5408037 Methods for detecting glucagon antagonists |
| 04/18/1995 | US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these |
| 04/18/1995 | US5407834 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit |
| 04/18/1995 | US5407833 For forming detectable complexes with autoimmune antibodies, kits |
| 04/18/1995 | US5407823 Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides |
| 04/18/1995 | US5407811 Monoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodies |
| 04/18/1995 | US5407810 Using chaotropic agent to extract exogenous peptide in non-native conformation in phase of polymer and salt |
| 04/18/1995 | US5407805 Monoclonal antibody reactive to various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
| 04/18/1995 | US5407803 Method for measuring the activity of angiotensin converting enzyme in biological samples |
| 04/18/1995 | CA1335264C Yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts |
| 04/13/1995 | WO1995009924A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009872A1 Dna encoding prostaglandin receptor ip |
| 04/13/1995 | WO1995009871A1 Novel antitumor peptide |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995009653A1 Antibodies to cd40 |
| 04/13/1995 | WO1995007934A3 Il8 inhibitors |
| 04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2151261A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/12/1995 | EP0647711A1 Plants transformed with a DNA sequence from bacillus thuringiensis lethal to lepidoptera |
| 04/12/1995 | EP0647277A1 Methods for using cks fusion proteins |
| 04/12/1995 | EP0647276A1 Protein preparations |
| 04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 04/12/1995 | EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
| 04/12/1995 | EP0647268A1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
| 04/12/1995 | EP0647238A1 INTERLEUKIN-1$g(b) DELETION MUTANT |
| 04/12/1995 | EP0647140A1 Papillomavirus vaccines |
| 04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 04/12/1995 | EP0567554B1 Method for the purification of intact, correctly-folded insulin-like growth factor-1 |
| 04/12/1995 | EP0478696B1 Efficient method for identifiable expression of non-selectable genes |
| 04/12/1995 | EP0429587B1 Process for obtaining a regulation protein (nef) for hiv-1 using the human cell line th4-7-5 |
| 04/12/1995 | EP0383764B1 Bovine granulocyte-macrophage colony stimulating factor |
| 04/12/1995 | EP0357672B1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
| 04/11/1995 | US5405945 DNA encoding reproductive hormones and expression using a minigene |
| 04/11/1995 | US5405942 Prepro insulin-like growth factors I and II |
| 04/11/1995 | US5405785 Derivatives of cyclosporine A, antibodies directed thereto and uses thereof |
| 04/11/1995 | US5405759 Heparitinase, process for producing the same and bacteria producing the same |
| 04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
| 04/11/1995 | US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems |
| 04/11/1995 | US5405637 Milk protein partial hydrolysate and infant formula containing same |
| 04/11/1995 | CA1335182C Cellulose binding fusion proteins |
| 04/11/1995 | CA1335180C Anti-thrombin-binding substance monoclonal antibodies, hybridomas producing same, as well as purification process and assay of thrombin-binding substance making use of said monoclonal antibodies |
| 04/06/1995 | WO1995009241A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 04/06/1995 | WO1995009187A1 Monoclonal antibody and assay of denatured dna by using the same |
| 04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 04/06/1995 | WO1995009184A1 Use of relaxin as an analgesic and palliative for intractable pain |
| 04/06/1995 | WO1995009182A1 Protective antigens against parasites |
| 04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | WO1995009002A1 Methods of inhibiting phagocytosis |
| 04/06/1995 | WO1995007466A3 Biotin-analog conjugated antibodies for positive cell selection and release |
| 04/06/1995 | WO1995006744A3 Methods of suppressing immune response by gene therapy |
| 04/06/1995 | WO1995006718A3 Methods of suppressing autoimmune response |
| 04/06/1995 | WO1995006717A3 Methods of suppressing graft rejection |
| 04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | CA2172728A1 Vaccine for branhamella catarrhalis |
| 04/06/1995 | CA2172492A1 Protective antigens against parasites |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |